As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge economic investment for the company, and the small town.

Merck plans to spend $895 million to expand a De Soto, Kansas, manufacturing facility for its animal health segment, the ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Rahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug ...

Merck has received approval from the Food and Drug Administration for Welireg, its oral inhibitor for patients with certain rare types of neuroendocrine tumors. The company said Wednesday the ...